| Literature DB >> 20066047 |
Daniel J M Fernández-Ayala1, Shanjun Chen, Esko Kemppainen, Kevin M C O'Dell, Howard T Jacobs.
Abstract
BACKGROUND: A point mutation in the Drosophila gene technical knockout (tko), encoding mitoribosomal protein S12, was previously shown to cause a phenotype of respiratory chain deficiency, developmental delay, and neurological abnormalities similar to those presented in many human mitochondrial disorders, as well as defective courtship behavior. METHODOLOGY/PRINCIPALEntities:
Mesh:
Substances:
Year: 2010 PMID: 20066047 PMCID: PMC2798955 DOI: 10.1371/journal.pone.0008549
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Crossing scheme to generate maximally outbred tko mutant flies for analysis.
Balanced stocks were used first to create homozygous females and hemizygous males of the two parental backgrounds, in order to include in the analysis any maternal effects of the mutation. Note that tko is an X-chromosomal gene. The initial outbreeding to create the balanced stocks restores a wild-type genetic background, but does not completely eliminate any potentially compensatory recessive alleles already in the wild-type backgrounds. To minimize the effects of any such alleles, the crossing scheme illustrated is both maximally wild-type and heterozygous, under which conditions we saw the most substantial accentuation of the mutant phenotype, compared with inbred tko lines [115].
Number of selected probes during filtering and statistical analysis.
| number of probe sets | % of total | |||
| male | female | male | female | |
|
| ||||
| detection p-value <0.05 | 10110 | 9778 | 53% | 52% |
|
| ||||
| Fold change (R)>1.5 | 1248 | 662 | 7% | 3% |
| both R>1.5 and FDR<5% | 947 | 413 | 5% | 2% |
|
|
|
|
|
|
% of probe sets in the array, to nearest whole number. GeneChip® Drosophila Genome 2.0 Array contains 18952 probe sets.
FDR = 58%.
FDR = 34%.
Coherence of changes in gene expression by sex.
| Regulated genes | % of regulated genes | % of total genes | |
| male up (total) | 404 | 54% | 2.1% |
| male down (total) | 347 | 46% | 1.8% |
| female up (total) | 268 | 76% | 1.4% |
| female down (total) | 85 | 24% | 0.4% |
| both sexes up | 102 | 14% (m), 29% (f) | 0.54% |
| both sexes down | 32 | 4% (m), 9% (f) | 0.17% |
| male up female down | 3 | 4‰ (m), 8‰ (f) | 0.02% |
| male down female up | 1 | 1‰ (m), 3‰ (f) | 0.01% |
Number of genes regulated in the directional manner shown. For a graphical illustration see .
% of the genes regulated in that sex.
% of probe sets in the array. GeneChip® Drosophila Genome 2.0 Array contains 18952 probe sets.
Genes showing largest alterationsa in expression in tko.
| Gene | Function | FC (male) | FC (female) | Chromosomal localization | ||
| Array | Q-PCR | Array | Q-PCR | |||
|
| ||||||
|
| Mdr-related ABC transporter, xenobiotic clearance | 43.0 | 11.7 | 45D1 | ||
|
| Lsp receptor, aminoacid/nutrient transport | 17.6 | 81 | (33.7) | 159 | 70D2 |
|
| Lsp receptor, aminoacid/nutrient transport | 16.5 | (17.9) | 30B3 | ||
|
| unknown function | 12.2 | (19.2) | 35B5 | ||
|
| odorant-binding lipohilic protein | 13.6 | 2 | (17.0) | 17 | 99B8 |
|
| lipohilic hormone-binding protein | 12.5 | (18.0) | 3B2 | ||
|
| gut-specific triacylglycerol lipase | 9.6 | 17.9 | 97D14 | ||
|
| cytochrome P450, xenobiotic metabolism | 10.9 | 9.2 | 51D1 | ||
|
| serine protease | 12.2 | 5.8 | 66F4 | ||
|
| long-chain fatty acyl-CoA synthetase | 6.7 | 5 | 9.4 | 36 | 92B2 |
|
| heat-shock protein | 11.9 | 25 | 4.2 | 6 | 67B2 |
|
| endonuclease | 5.7 | 10.4 | 75E6 | ||
|
| actin filament organization | 14.1 | (1.8) | 18B6 | ||
|
| glucuronosyltransferase, xenobiotic metabolism | 10.9 | (3.9) | 87C8 | ||
|
| aminoacid/other nutrient transport | 7.2 | (6.9) | 11A12 | ||
|
| cytochrome P450, xenobiotic metabolism | 9.2 | (4.8) | 30C7 | ||
|
| unknown function | 6.6 | (7.2) | 34E5 | ||
|
| aminoacid/other nutrient transport | 6.3 | (6.6) | 21E2 | ||
|
| endonuclease | 5.4 | 7.2 | 98E1 | ||
|
| unknown function | 6.8 | 5.2 | 8C17 | ||
|
| sodium-dependent aminoacid transporter | 4.6 | 7.3 | 55E10 | ||
|
| aminoacid/other nutrient transport | 6.0 | (5.6) | 61A6 | ||
|
| gut-specific, chitin metabolism | 1.9 | 8.4 | 29C1 | ||
|
| unknown function, protein-binding properties | 6.1 | (4.2) | 96C9 | ||
|
| intracellular protein transport | 3.7 | 6.4 | 85E4 | ||
|
| glucuronosyltransferase, xenobiotic metabolism | 5.4 | 3.7 | 86D4 | ||
|
| triacylglycerol lipase | 5.5 | 2.5 | 5D1 | ||
|
| urate oxidase | (1.9) | 5.7 | 28C3 | ||
|
| gut-specific serine protease | (1.9) | 5.7 | 25B4 | ||
|
| serine protease | 5.8 | 1.7 | 19E5 | ||
|
| unknown function | 3.4 | 3.4 | 21E2 | ||
|
| glutathione-S-transferase, xenobiotic metabolism/clearance | 4.7 | 2.0 | 55C6 | ||
|
| aminoacid/other nutrient transport | 3.8 | (2.7) | 68F5 | ||
|
| actin-binding protein | 3.4 | 3.1 | 85E4 | ||
|
| galactose-binding lectin | 4.0 | 2.5 | 28D2 | ||
|
| unknown function | 3.7 | 2.8 | 61D4 | ||
|
| cytochrome P450, xenobiotic metabolism | 3.3 | 3.1 | 51D1 | ||
|
| gut-specific serine protease | (1.8) | 4.5 | 25B4 | ||
|
| gram-negative bacterial binding | 3.1 | 3.0 | 44D2 | ||
|
| 4-hydroxyphenylpyruvate dioxygenase (aminoacid catabolism) | 2.3 | 3.8 | 77C3 | ||
|
| selenocysteine methyltransferase (aminoacid catabolism) | 2.7 | 3.1 | 37B7 | ||
|
| steroid dehydrogenase | 4.1 | 1.7 | 36B2 | ||
|
| PEP carboxykinase (GTP) 2 | 1.8 | nt | 4.0 | 2,5 | 55D3 |
|
| positive regulator of fatty acid β-oxidation in response to cold | 2.0 | 3.8 | 85E2 | ||
|
| lactate dehydrogenase | 2.6 | 1.5 | 3.1 | 4 | 65A11 |
|
| heat-shock protein | 3.4 | 2.1 | 67B3 | ||
|
| Malpighian tubule-specific steroid carrier | 2.6 | 2.8 | 47C5 | ||
|
| calciphotin, calcium-binding, involved in eye development | 2.3 | 3.1 | 87B1 | ||
|
| alkaline phosphatase, skeletal development | 1.8 | 3.6 | 64D5 | ||
|
| gut-specific serine protease | 2.7 | 2.6 | 47F4 | ||
|
| nucleotide phosphatase | 2.6 | 2.7 | 54B17 | ||
|
| gut-specific, chitin metabolism | 2.2 | 3.0 | 29C1 | ||
|
| unknown function | 1.8 | 3.3 | 55B1–55B2 | ||
|
| sugar transport | 2.8 | 2.2 | 23E4 | ||
|
| tenascin, Wnt-signalling receptor-related | 2.1 | 2.9 | 34E5 | ||
|
| cytochrome P450, xenobiotic metabolism | 2.6 | 2.4 | 34E5 | ||
|
| cofactor for tRNA synthetase | 2.5 | 2.5 | 50F6 | ||
|
| ||||||
|
| Rieske iron-sulfur protein, OXPHOS complex III (isoform A) | −27.3 | −33.1 | 22A3 | ||
|
| tyrosyl-DNA phosophodiesterase (DNA repair) | −5.4 | −5.2 | 23D3 | ||
|
| intergenic region | −6.1 | −4.5 | 82A4 | ||
|
| ion channel inhibitor with direct antimicrobial effect | −4.3 | −4.3 | 63D1 | ||
|
| ovary-specific unknown protein-binding protein (unlocalized gene) | −1.7 | −6.8 | 41C1–41C6 | ||
|
| PEP carboxykinase (GTP) 1 | −3.7 | −(4.5) | 55D1 | ||
|
| humoral stress response protein | −5.0 | −(2.0) | 93A3 | ||
|
| deoxyribodipyrimidine photo-lyase (DNA repair) | −3.4 | −2.8 | 43E18 | ||
|
| aminoacids transporter | −2.1 | −4.1 | 67B10 | ||
|
| mesoderm development | −3.2 | −2.7 | 100A3 | ||
|
| unknown function | −2.9 | −2.7 | 38B1 | ||
|
| cytochrome P450, xenobiotic metabolism | −3.4 | −2.0 | 20A1 | ||
|
| ||||||
|
| sperm-specific dynein intermediate chain | 8.0 | n.c. | 19C1 | ||
|
| lipohilic hormone-binding protein, behavioural regulator | −2.1 | −5 | n.c. | −2 | 96C7 |
|
| glucose oxidase/dehydrogenase | −3.1 | n.c. | 84D3 | ||
|
| pole cell development | −8.8 | n.c. | 85B7 | ||
|
| unknown function, protein-binding properties | n.c. | 15.7 | 18C7 | ||
|
| gut-specific lysozyme | n.c. | 7.0 | 61F3 | ||
|
| sphingomyelin phosphodiesterase | n.c. | 6.4 | 99F4 | ||
|
| defense against Gram-positive bacteria | n.c. | 4.6 | 44E2 | ||
| α | carboxyesterase | n.c. | −3.3 | 84D8–84D9 | ||
|
| mitochondrial-targeted, unknown function | 2.2 | −1.7 | 2D4 | ||
|
| small GTPase | 1.6 | −1.9 | 3E5–3E6 | ||
|
| female-specific of | −3.0 | 1.9 | 93F14 | ||
|
| ||||||
|
| transposon | 22.3 | 10.2 | --- | ||
|
| transposon | 13.3 | 13.2 | --- | ||
|
| transposon | 8.9 | 7.4 | --- | ||
|
| transposon | 6.6 | (2.5) | --- | ||
|
| transposon | 2.7 | 2.4 | --- | ||
|
| transposon | −2.3 | −5.9 | --- | ||
|
| transposon | −2.5 | −3.2 | --- | ||
|
| transposon | −5.6 | −4.2 | --- | ||
|
| transposon | 1.7 | −2.0 | --- | ||
Average of >2-fold change, both sexes considered, except in regard to genes with proven or probable sex-specific functions, where >2-fold change in only one sex was sufficient for inclusion in this list. For full list of alterations in gene expression, including details of relevant Affymetrix probe sets, see Table S3.
Excluding genes normally expressed only in the opposite sex from that in which regulation was observed, or genes tightly inducible by a defined stress, e.g. bacterial infection, and which are normally expressed at a very low level in both sexes.
Fold change, i.e. proportionate increase from wild-type (positive numbers) or to wild-type (negative numbers), in each sex. In parenthesis, those regulated genes that were unselected by the statistical analysis with the threshold that we used. Unaffected genes are denoted as no change (n.c.). Data shown alongside from the Affymetrix array experiment correspond to Q-RT-PCR analyses, where performed nt–not tested.
Gene model currently withdrawn, probe set detects an ovary-specific transcript (flyatlas.org) at 41C1–41C6, but full genomic sequence not identified.
Figure 2Wolbachia infection does not explain the abnormal metabolism or courtship behaviour of tko flies.
PCR reactions analysed on agarose gels, using Wolbachia-specific 16S rDNA and Drosophila mitochondrial 12S rDNA primers. The 897 bp Wolbachia-specific product (arrowed) is detected only in the Wolbachia-infected strain obtained from the Bloomington Stock Center (wol), and not in wild-type (+) or tko flies in either the Oregon R (OR) or Canton S (CS) backgrounds, nor in inbred laboratory stocks of the sesB or to mutants. The 180 bp mitochondrial DNA product is evident in all strains tested. M, 1 kb marker ladder.
Figure 3Reproductive defects of outbred tko females.
(a) The number of eggs laid per mated female was counted daily for individual mated females from the crosses indicated. Asterisks indicate significant differences (p<0.01, t-test). (b) Single mating pairs of the genotypes shown were observed for time to copulation.
Figure 4Quantitative RT-PCR verification of transcriptomic data on takeout.
RNA measurements were made and normalized as described in Materials and Methods. Means±SD of three sample runs of each of three biological replicates are shown. Significance at the p value shown was computed using a t-test. See also Table 3.
Figure 5Summary of major alterations to gene expression and their proposed effects in tko flies.
(a, b) Proposed metabolic effects, based on differences in gene expression affecting nutrition and metabolism between (a) wild-type and (b) tko flies. In wild-type flies glucose is metabolized via PEP to pyruvate, which is then fed to the TCA cycle mainly via the pyruvate dehydrogenase complex generating acetyl-CoA, with a small amount converted to oxaloacetate to replenish the TCA cycle intermediates as needed, maintaining a supply of carbon skeletons for biosynthesis. Surplus NADH is reoxidized via the ETC (complexes I, III and IV), generating potentially most of the cell's ATP needs at complex V. In tko flies, the maximal activity of the ETC complexes is only 10–20% that of wild-type flies [18]. For simplicity, its greatly decreased contribution to NADH oxidation and ATP generation is omitted altogether in panel (b). Instead, the bulk of ATP must be supplied by glycolysis, with NADH reoxidation dependent on lactate dehydrogenase and similar shunts. Because pyruvate is, under such conditions, mainly shunted to lactate, the TCA cycle must be supplied from other sources, via the mobilization of dietary lipids, generating acetyl-CoA, PEP carboxykinase (I) diverting a small amount of PEP to oxaloacetate, and the mobilization of dietary protein and amino acid catabolism supplying these and other TCA cycle intermediates, as well as biosynthetic reactions directly. The modifications to metabolism in tko flies are accompanied (c) by altered expression of genes connected with nutrient breakdown, absorption and transport, plus xenobiotic handling, affecting mainly the gut, Malpighian tubule and fat body. In addition, there is downregulation or delayed expression of genes connected with gametogenesis and skeletogenesis, and, notably in males, altered expression of genes controlling circadian and courtship behaviour, interpretable as a biological response to poor nutritional conditions.